Alexza Reports Fourth Quarter and Year End 2015 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/2/2026
- Wall St ends higher as stocks reclaim some shine
- Oil settles 1% higher, as US-Iran strikes threaten supplies
- Dell again lifts annual forecasts as AI demand powers record results
- Could Apple’s foldable iPhone be a $14B opportunity? Morgan Stanley weighs in
- Uber stock gains 2% as tech giant cuts 3,300 jobs in major restructuring
- GoPro to merge with Starman Optical in $285M recapitalization deal
- GoPro (GPRO) Halted, News Pending
- Crude Inventory Fell 4.5M Barrels Last Week - EIA
- Wall Street ends lower as higher yields, rising oil prices mark shaky start to September
- TScan cuts 75% of workforce, pivots to solid tumor cell therapy
Alexza Pharma (ALXA) Reports Q4 Loss of $0.15/Share; Warns it May Shut Down
March 28, 2016 4:12 PM EDTAlexza Pharma (NASDAQ: ALXA) reported Q4 EPS of ($0.15), versus ($0.35) reported last year. Revenue for the quarter came in at $673 thousand, versus $1.45 million reported last year.
Alexza believes that, based on its cash and cash equivalent balances at December 31, 2015, the additional $1.0 million drawn... More
